18 F-Fluoro-5α-Dihydrotestosterone
Small moleculeexperimentalImaging agent
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 31, 2014 (NCT01988324)
Timeline
Indications
Studied for
Mechanism of action
- Androgen ReceptorBINDING AGENT
AR binding agent
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Also known as
- fdht
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06145399 | Early Phase 1 (Phase 1) | Oct 24, 2023 | Memorial Sloan-Kettering Cancer Center |
| NCT02697032 | Phase 2 | Feb 1, 2016 | University of Groningen |
| NCT01988324 | Phase 2 | Aug 31, 2014 | University of Groningen |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Groningen | Academic/Hospital | 2 | 2 | 1 | 2014 |
| Memorial Sloan-Kettering Cancer Center | Academic/Hospital | 1 | 1 | 1 | 2023 |
2 organizations
Page 1 / 1